Exchange of Thailand The Board of Directors meeting of KGI Securities (Thailand) Plc (“the Company”), No.1/2020, held on 19th February 2020, approved the audited financial statements, including the

the year ended December 31, 2019 To Director and Manager the Stock Exchange of Thailand According to the Board of Directors’ Meeting No.2/ 2 0 2 0 of DOD Biotech Public Company Limited ( “ the Company

for Q2/2017 ended June 30, 2017 of the Company and its subsidiaries, as shown below : (Unit : Million Baht) Q2/2017 Q2/2016 Change Revenue 222 210 12 Gross profit margin 80 83 (3) Expenses 20 20

; According to the Board of Directors’ Meeting of Oishi Group Public Company Limited No. 1/2016, which was held on 25 February 2016, has approved the change in the Company’s accounting period from 1 January and

Exchange of Thailand The Board of Directors meeting of KGI Securities (Thailand) Plc (“the Company”), No.1/2018, held on 26th February 2018, approved the audited financial statements, including the

. OCMSET / 1905/002 May 8, 2019 Subject: Clarification of the operating results for the three-month period of 2019, change of rate more than 20 percent Dear Director and Manager the Stock Exchange of

Exchange of Thailand The Board of Directors’ Meeting of Ladprao General Hospital Public Company Limited (the “Company”), No.6/2018, held on August 10, 2018, has approved the financial statements of the

to submit our management’s discussion and analysis for the second quarter in 2019, ended on June 30, 2019 as follows: (Unit : Million Baht) Jan - Jun 2019 Jan - Jun 2018 Increased/ (Decreased) % Change

, net profit amounted to THB 39.1 million, a decrease of THB 126.2 million or 76.4% from the same period last year. The main factor causing the operating results of the second quarter of 2020 to change

) % Change 2019 2018 Sales revenue 274.53 224.09 50.44 22.51% Other incomes 3.77 0.74 3.03 409.46% Total revenues 278.30 224.83 53.47 23.78% Cost of sales 117.60 85.18 32.42 38.06% Selling expenses 82.72 61.72